Welcome to licensed pharmacies in Poland:

Non-prescription medicines delivery across Europe.

Frequently ordered: potency boosters (sildenafil OTC), quit smoking aids.

Jasia (Anonymous, 77.172.187.) Warszawa 19 months ago

Is it true that Qlaira is two-component and that it is very harmful?

I take qlair for over 10 years, I have Edometriosis, when taking pills I have less bleeding, and often at all, which is why I do not have such terrible pains, recently I read that qlaira is two-component, and that it is very harmful, is it true, whether you can take these pills for so long

1 answer

* required field

You can drag the photo file here.

* required field

Notify of a new answer.
Other messages will not be sent.

Olga Sierpniowska Pharmacist, Editor

19 months ago

Indeed, Qlaira is a two-component drug, since it contains two types of hormones - estrogen and progestin. Unfortunately, I do not know what kind of "harmfulness" you have read about. Any medication may or may not cause side effects. If the preparation causes you to have small bleeding, do not feel pain and there are no side effects, it seems that in your case everything is fine. There are no time limits in the use of preparations such as Qlaira - the product can be used as long as the doctor deems it justified. Of course, it is advisable to check and regularly perform examinations according to the recommendation of the gynecologist. I enclose our materials that may be of interest to you: https://www.gdziepolek.pl/produkty/65571/qlaira-tabletki-powlekane/apteki/w-warszawie https://www.gdziepolek.pl/artykuly/czy-bac-sie-dzialan-niepozadanych-lekow https://www.gdziepolek.pl/artykuly/bol-i-nieplodnosc-czyli-endometrioza

Appreciate the answerer and highlight the question on the home page
User questions and answers that provide feedback about products are not verified for the purchase or use of the product. Companies often order anonymous comments to form positive opinions about their products, or negative ones about competitors. Therefore, be guided by the information in the pharmacists' responses in the first place.

Specialists